REG-The Biotech Growth Trust Plc: Net Asset Value(s)

Biotech Growth TrustAnnouncement

05/10/2023 16:15

THE BIOTECH GROWTH TRUST PLC

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance
with the guidelines of the Association of Investment Companies, for The
Biotech Growth Trust PLC at the close of business on 4 October 2023 was
797.70p (cum income).

Note: The valuation of StemiRNA (a private Chinese biotech company which
comprised 1.75% of the Company's portfolio at 3 October 2023 has been reduced
by 74% pursuant to the most recent valuation which was received by the Company
after market close yesterday.  The valuation was produced by Kroll, an
independent third-party valuer, and has been reviewed and agreed by the AIFM
and the Company's Valuation Committee.

The effect of the revaluation is a 1.3% decline in the Company's NAV, which
has been incorporated into the NAV with immediate effect including, for the
avoidance of doubt, in the above NAV figure.  The valuation declined on the
expectation that the company's next financing round will be at a substantially
lower valuation to the previous round.  Further details will be provided in
the Company's September fact sheet and forthcoming half yearly report for the
six months ended 30 September 2023.

For and on behalf of the Board

Frostrow Capital LLP

Secretary

05 October 2023



Copyright (c) 2023 PR Newswire Association,LLC. All Rights Reserved